Phosphorylated tau: toxic, protective, or none of the above
about
Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing ProblemChronic effects of mild neurotrauma: putting the cart before the horse?Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neuronsBiomarkers in Alzheimer's disease: past, present and future.Genetics and biology of Alzheimer's disease and frontotemporal lobar degenerationVersatile somatic gene transfer for modeling neurodegenerative diseases.Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies.The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's diseaseFrontiers in Alzheimer's disease therapeutics.Disease-modifying treatments for Alzheimer's disease.EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease.Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegenerationDysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Neuronal models for studying tau pathology.Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology.The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease.Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β.Tau Phosphorylation by GSK3 in Different Conditions.The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.Dementia Pugilistica Revisited.Three-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer's disease patients.How the formation of amyloid plaques and neurofibrillary tangles may be related: a mathematical modelling study.
P2860
Q27004724-474A2F14-66BE-4763-A967-8E8F74F0BAF5Q28394156-6E4D5072-522B-4CD5-97BC-7895A1ACF401Q30542949-1977C6C5-E38D-42A4-90DD-2A798736905BQ33791646-EAB771D2-477F-4639-8CCD-C9CFD6F1F697Q33951192-90469DA8-19DB-428B-B9F2-C91E8D2907D7Q34285870-40262CE5-663B-4927-AEDC-22AA8BE7BBC7Q34545616-BF08895C-962B-4151-8086-01A9648232B0Q35071628-8F97D622-7336-4796-8DC3-C40F06569152Q35086876-3CE4B5F8-FBC0-47B7-8D78-81767F3E1FBBQ35090423-EEC41285-D0A3-4F74-8EE0-E22F5D9F1988Q36912641-1BB68BC3-B901-40D1-8012-9F7EF300A9EFQ36999161-0F2218DC-8603-416B-B3F1-6673EB80A654Q37402339-EBB730F1-2E33-447D-B0A4-8301599883C0Q37524486-15C73D87-6372-42A2-A066-65ECD50864A8Q37780959-9DE4AA28-AA84-4A1F-9804-F63D1B1AA7D6Q40730087-79B1AB32-CC05-4F46-A0E2-6A6A7E5359B4Q41573050-8A56FA53-68AB-4353-A50F-2BD733B795B0Q41872252-01917A8F-7AB1-4329-BA81-41CBDE1813E2Q42180899-07D602E5-6FF7-4D87-A6D0-F609A81A9357Q46251905-8A3E8BC2-3F7C-4B49-A341-5600CDCAF540Q47131948-60982C2D-6A62-4414-95B7-54646DF8DFD1Q50533053-0E4C4BE3-5509-446C-869F-A5150A104711Q53396189-D603B6AE-0C76-4341-966D-F1BC48991D66
P2860
Phosphorylated tau: toxic, protective, or none of the above
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphorylated tau: toxic, protective, or none of the above
@en
Phosphorylated tau: toxic, protective, or none of the above.
@nl
type
label
Phosphorylated tau: toxic, protective, or none of the above
@en
Phosphorylated tau: toxic, protective, or none of the above.
@nl
prefLabel
Phosphorylated tau: toxic, protective, or none of the above
@en
Phosphorylated tau: toxic, protective, or none of the above.
@nl
P2093
P2860
P356
P1476
Phosphorylated tau: toxic, protective, or none of the above
@en
P2093
Akihiko Nunomura
George Perry
Hyoung-gon Lee
Mark A Smith
Rudy J Castellani
P2860
P304
P356
10.3233/JAD-2008-14404
P577
2008-08-01T00:00:00Z